Gallifrey Tablet
Product Images NDC 70700-326

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Gallifrey (NDC 70700-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norethindrone Acetate Structural Formula (Image 01)

Norethindrone Acetate Structural Formula (Image 01)
Chemical structure diagram of norethindrone acetate, the active ingredient in Gallifrey 5 mg oral tablets by Xiromed LLC. The diagram shows the molecular structure including rings and functional groups characteristic of norethindrone acetate.*
FDA Label Image

Figure 1. Mean Plasma Concentration Profile After A Single Dose Of 5 mg Administered To 29 Healthy Female Volunteers Under Fasting Conditions (Image 02)

Figure 1. Mean Plasma Concentration Profile After A Single Dose Of 5 mg Administered To 29 Healthy Female Volunteers Under Fasting Conditions (Image 02)
A line graph showing concentration (ng/ml) versus time (hours) over a 36-hour period. The concentration peaks sharply early on and then gradually declines over the time course shown.*
FDA Label Image

5 mg Bottle Label (Image 03)

5 mg Bottle Label (Image 03)
Gallifrey 5 mg tablets packaging label by Xiromed LLC displays Norethindrone Acetate as the active ingredient. The label indicates 50 tablets in the package for oral administration, highlighting it as an orally active progestin. Includes dispensing instructions, storage conditions, and safety precautions. The label features barcodes and a QR code linking to patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.